The emerging therapy of the medication represents a significant advance in the management of type 2 diabetes. Distinct from existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide399405.gynoblog.com/40714322/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment